As a mechanistic explanation, Mathew et al. recently discovered that Sorafenib increases IL-15 production by FLT3-ITD+ leukemia cells in mice and human thereby inducing leukemia-reactive T cells [98]. The gene discussed is IL15; the disease is leukemia.